Difference between revisions of "Part:BBa K929107"
| Line 3: | Line 3: | ||
{| style="color:black" cellpadding="6" cellspacing="1" border="2" align="right" | {| style="color:black" cellpadding="6" cellspacing="1" border="2" align="right" | ||
| − | ! colspan="2" style="background:#66bbff;"|[https://parts.igem.org/Part:BBa_K929007 Anti-GFP, IgG1 Fc with TEV site, | + | ! colspan="2" style="background:#66bbff;"|[https://parts.igem.org/Part:BBa_K929007 Anti-GFP, IgG1 Fc with TEV site, TMD, mCherry, framed by LoxP] |
|- | |- | ||
! colspan="2"|[[Image:UP12_BBa_K929107.png|300px]] | ! colspan="2"|[[Image:UP12_BBa_K929107.png|300px]] | ||
Revision as of 22:37, 26 September 2012
Anti-GFP, IgG1 Fc with TEV site, TMD, mCherry, framed by LoxP
| Anti-GFP, IgG1 Fc with TEV site, TMD, mCherry, framed by LoxP | |
|---|---|
| |
| BioBrick Nr. | BBa_929107 |
| RFC standard | RFC 25 |
| Requirement | pSB1C3 |
| Source | Gene synthesis by GeneArt |
| Submitted by | [http://2012.igem.org/Team:Potsdam_Bioware Potsdam_Bioware2012] |
The antibody construct consists of two major building blocks represented by the actual antibody unit ( BBa_K929102) and the switchable membrane anchoring region (BBa_K929103). Both elements guarantee the eligibility and the easy handling of the construct and are optimized for expression in CHO cells. The antibody unit is represented by the human Ig kappa chain V-I region signal peptide (UniProt: P01601), the anti-GFP Nanobody (PDB: 3OGO) and the Fc region (UniProt: P01857). TEV protease recognition site, 2 LoxP sites, the B-cell receptor transmembrane domain (modified BBa_K157010) and the mCherry reporter display the switchable membrane anchoring region.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]